Info

The PMRExam Podcast

PMR Board Prep instructor and PMRExam's creator, David Rosenblum, MD discusses issues relevant to Physiatrists and Pain Physicians. Dr. Rosenblum's Physical Medicine and Rehabilitation Podcast, The PMRExam Podcast, features, interviews, board prep and practice management issues relevant to rehab physicians. For more information on Physiatry board prep and CME credits, go to PMRExam.com
RSS Feed Subscribe in Apple Podcasts
The PMRExam Podcast
2022
August
July
June
May
April
March
February
January


2021
December
November
October
September
August
July
June
May
April
March
February
January


2020
December
November
October
September
August
July
June
May
April
March
February
January


2019
December
November
October
September
August
July
June
May
April
March
February
January


2018
December
November
October
September
August
July
May
January


2017
October
September
July
June
May
April
March
February
January


2016
November
August
July
June
May
April
March
February
January


2015
December
November
October
September
August
July
June
May


Categories

All Episodes
Archives
Categories
Now displaying: Page 1
Jun 16, 2020

 

Low Dose Naltrexone for Pain

New Courses at PainExam

Ultrasound Series

Regenerative Spine Pain Course

Regenerative Medicine

Regenerative Medicine Spine Pain Course

 

Dr. Rosenblum Discusses the uses and theory behind Low Dose Naltrexone for Chronic Pain and Inflammation.

References

Debasish Hota, MD, DM, Anand Srinivasan, MD, Pinaki Dutta, MD, DM, Anil Bhansali, MD, DM, Amitava Chakrabarti, MD, DM, Off-Label, Low-Dose Naltrexone for Refractory Painful Diabetic Neuropathy, Pain Medicine, Volume 17, Issue 4, April 2016, Pages 790–791, https://doi.org/10.1093/pm/pnv009

Younger et al: The Use of Low-Dose Naltrexone (LDN) as a Novel Anti-Inflammatory Treatment for Chronic Pain. Clinical Rheumatology (2014) 33:451-459

KTojan, VroomanB.  Low-Dose Naltrexone (LDN) review of Therapeutic Utilization. Med. Sci. 2018, 6,82

0 Comments
Adding comments is not available at this time.